SAR125884

CAS No. 1116743-46-4

SAR125884( —— )

Catalog No. M20207 CAS No. 1116743-46-4

SAR125844 a potent and highly selective inhibitor of the MET receptor tyrosine kinase (RTK) for intravenous administration.?(IC50 value of 4.2 nmol/L).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 40 In Stock
5MG 65 In Stock
10MG 106 In Stock
25MG 215 In Stock
50MG 345 In Stock
100MG 560 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    SAR125884
  • Note
    Research use only, not for human use.
  • Brief Description
    SAR125844 a potent and highly selective inhibitor of the MET receptor tyrosine kinase (RTK) for intravenous administration.?(IC50 value of 4.2 nmol/L).
  • Description
    SAR125844 a potent and highly selective inhibitor of the MET receptor tyrosine kinase (RTK) for intravenous administration.?(IC50 value of 4.2 nmol/L).
  • In Vitro
    Cell Proliferation Assay Cell Line:H-460 cells, HCT116 cells, H1993 cells, EBC-1 cells, SNU-5 cells, OE33 cells, Hs 746T cells and MKN-45 cellsConcentration:1 nM, 3 nM, 10 nM, 30 nM, 100 nM, 300 nM, 1000 nM, 3000 nM, 10000 nMIncubation Time:96 hResult:Inhibited cell proliferation in all cell lines with MET gene amplification, with IC50 values in the nanomolar range (1-7 nM), with the exception of the lung cancer cell line NCI-H1573.Apoptosis Analysis Cell Line:SNU-5 cells Concentration:1 nM, 3 nM, 10 nM, 30 nM, 100 nM, 300 nM Incubation Time:24 h, 48 h, 72 h Result:Induced massive apoptosis in SNU-5 cells at 48 and 72 hours, with a relative EC50 value of 6 nM and a plateau of 60% at 72 hours.Cell Migration Assay Cell Line:H-460 cells, HCT116 cells, H1993 cells, EBC-1 cells, SNU-5 cells, OE33 cells, Hs 746T cells and MKN-45 cells Concentration:3 nM, 10 nM, 30 nM, 100 nM, 300 nM, 1000 nMIncubation Time:20 h Result:Inhibited cell migration with an IC50 value of 26 nM。
  • In Vivo
    Animal Model:SNU-5 and Hs 746T tumor-bearing miceDosage:45 mg/kg Administration:Intravenous injection (i.v.)Result:Resulted in complete and almost complete tumor regression in 3 of 8 mice and 5 of 8 mice, respectively. Animal Model:MET-amplified gastric tumor model mice Dosage:5 mg/kg, 11 mg/kg, 21 mg/kg, 53 mg/kg, 106 mg/kg, 213 mg/kg Administration:Intravenous injection (i.v.)Result:Resulted complete tumor regression in 7 of 8 of mice at 53, 106, and 213 mg/kg and partial regression at 11 and 21 mg/kg.Showed more than 80% MET inhibition at all doses and maintained for 96 hours at 213 mg/kg, 72 hours at.106 mg/kg, and 48 hours at 53 mg/kg.Showed complete or near-complete regression (92%–99%) and maintained for 7 days at 106 mg/kg, and 48 hours at 53 mg/kg.
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    c-Met/HGFR
  • Recptor
    MET RTK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1116743-46-4
  • Formula Weight
    550.63
  • Molecular Formula
    C25H23FN8O2S2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:45 mg/mL (81.72 mM)
  • SMILES
    Fc1ccc(cc1)-c1ccc2nnc(Sc3ccc4nc(NC(=O)NCCN5CCOCC5)sc4c3)n2n1
  • Chemical Name
    1-(6-((6-(4-fluorophenyl)-[124]triazolo[43-b]pyridazin-3-yl)thio)benzo[d]thiazol-2-yl)-3-(2-morpholinoethyl)urea

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Egile C et al. The selective intravenous inhibitor of the MET tyrosine kinase SAR125844 inhibits tumor growth in MET-amplified cancer. Mol Cancer Ther. 2015 Feb;14(2):384-94.
molnova catalog
related products
  • AMG-337

    AMG-337 is a potent and selective inhibitor of MET with biochemical IC50 of 1 nM; inhibits of HGF-mediated MET phosphorylation in PC3 cells.

  • SOMG-833

    A potent, selective, ATP-competitive c-MET inhibitor with IC50 of 0.93 nM.

  • Tivantinib

    Tivantinib (ARQ-197)?is a potent, selective, non-ATP-competitive inhibitor of c-Met with Ki of 355 nM.